Intest Res Search

CLOSE


‘Intestinal Research’ (Intest Res) is the joint official publication of the Asian Organization for Crohn's and Colitis (AOCC), Chinese Society of IBD (CSIBD), Japanese Society for IBD (JSIBD), Korean Association for the Study of Intestinal Diseases (KASID), Taiwan Society of IBD (TSIBD) and Colitis Crohn's Foundation (India) (CCF, india).
The aim of the Journal is to provide broad and in-depth analysis of intestinal diseases, especially inflammatory bowel disease, which shows increasing tendency and significance.As a Journal specialized in clinical and translational research in gastroenterology, it encompasses multiple aspects of diseases originated from the small and large intestines.

Review

August 18, 2020


Management of Clostridioides difficile infection in patients with inflammatory bowel disease
Sahil Khanna
Intest Res. 2021;19(3):265-274.

Review

November 20, 2020


Effect of resistance exercise training on Crohn’s disease patients
Konstantinos Papadimitriou
Intest Res. 2021;19(3):275-281.

Original Article

August 18, 2020


Trends of inflammatory bowel disease at a tertiary care center in northern India
Ajit Sood, Kirandeep Kaur, Arshdeep Singh, et al.
Intest Res. 2021;19(3):282-290.

Original Article

May 26, 2020


Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
Sanchit Sharma, Arti Gupta, Saurabh Kedia, et al.
Intest Res. 2021;19(3):291-300.

Original Article

August 20, 2020


Is adalimumab safe and effective in patients with intestinal Behcet’s disease in real-world practice?
Yasuo Suzuki, Takashi Hagiwara, Mariko Kobayashi, et al.
Intest Res. 2021;19(3):301-312.

Original Article

November 25, 2020


Incidence and risk factors for venous thrombosis among patients with inflammatory bowel disease in China: a multicenter retrospective study
Jing Liu, Xiang Gao, Ye Chen, et al.
Intest Res. 2021;19(3):313-322.

Original Article

August 18, 2020


Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis
Shin Ju Oh, Ga Young Shin, Hosim Soh, et al.
Intest Res. 2021;19(3):323-331.

Original Article

June 2, 2020


Patterns of endoscopy during COVID-19 pandemic: a global survey of interventional inflammatory bowel disease practice
Yan Chen, Qiao Yu, Francis A. Farraye, et al.
Intest Res. 2021;19(3):332-340.

Original Article

November 10, 2020


Effect of gut microbiome on minor complications after a colonoscopy
Jae Hyun Kim, Youn Jung Choi, Hye Jung Kwon, et al.
Intest Res. 2021;19(3):341-348.

Could the geographic area influence the demographic profile of IBD patients in India?

Epub April 29, 2021

Could melatonin ameliorate the intestinal inflammation by modulating intestinal microbial composition?

Epub August 10, 2020

What are the risk factors for impaired ovarian reserve in young women of reproductive age with Crohn's disease?

Epub April 22, 2020

Who should continue the budesonide 2-mg foam treatment for up to week 6 in patients with mild-to-moderate distal ulcerative colitis?

Epub February 18, 2020

How common is family history of inflammatory bowel disease and how does it relate to the prognosis in patients with inflammatory bowel disease in Asia?

Epub October 13, 2019

Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study

Epub August 2, 2019

Influence of anti-tumor necrosis factor-alpha therapy on pregnant women with inflammatory bowel disease and their children’s immunity

Epub April 23, 2019

Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis

Epub February 7, 2019

Fecal immunochemical test and fecal calprotectin in ulcerative colitis

Epub November 1, 2018

Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease

Epub August 9, 2018

Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study

Epub May 8, 2018

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment

Epub February 5, 2018

Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease

Epub November 2, 2017

Long-term safety and efficacy of adalimumab for intestinal Behçet's disease

Epub September 1, 2017

  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD

ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 305, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2021 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next
Close layer
prev next